| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/22/2009 | CN101486756A Outer surface proteins, their genes, and their use |
| 07/22/2009 | CN101485882A Pharmaceutical formulation containing candida urate oxidase |
| 07/22/2009 | CN101485881A Multi-protein medicament for treating tumor |
| 07/22/2009 | CN101485880A Pharmaceutical composition for treating immunodeficiency symptoms |
| 07/22/2009 | CN100516220C Serine proteinase inhibitor of bifidobacteria |
| 07/22/2009 | CN100516217C Artificial synthesised scorpion chloride ion neurotoxin gene-rBmK CTa |
| 07/22/2009 | CN100516215C Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 07/22/2009 | CN100516087C Recombinant target fusion protein GnRH-TNFam and its antitumor use |
| 07/22/2009 | CN100515494C Immunisation against chlamydia trachomatis |
| 07/22/2009 | CN100515493C Injection for treating angitis |
| 07/22/2009 | CN100515492C Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, purpose thereof and method of making same |
| 07/22/2009 | CN100515491C Medical use of interleukin-22 |
| 07/21/2009 | US7563884 Antisense modulation of PTP1B expression |
| 07/21/2009 | US7563882 Comprises polypeptide for diagnosis and treatment of tumors; immunotherapy |
| 07/21/2009 | US7563881 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
| 07/21/2009 | US7563880 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/21/2009 | US7563874 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 07/21/2009 | US7563872 Gene coding, gene expression, purification; used as detergents, cosmetics, leather processing, softening for food, meats, animal feeds |
| 07/21/2009 | US7563871 Polymer-based sustained release device |
| 07/21/2009 | US7563868 NRIF3, a novel co-activator for nuclear hormone receptors |
| 07/21/2009 | US7563867 PRO4356 polypeptides |
| 07/21/2009 | US7563866 Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses |
| 07/21/2009 | US7563865 Microwave-assisted peptide synthesis |
| 07/21/2009 | US7563862 Neural regeneration peptides and methods for their use in treatment of brain damage |
| 07/21/2009 | US7563778 Antisense oligonucleotide preparation method |
| 07/21/2009 | US7563777 Method to induce neovascular formation and tissue regeneration |
| 07/21/2009 | US7563776 First sequence of human low affinity nerve growth factor receptor or a polynucleotide coding for it and a second sequence of a mutant hiv nef gene or a polynucleotide coding for it |
| 07/21/2009 | US7563775 Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes |
| 07/21/2009 | US7563772 Methods of increasing cerebral blood flow |
| 07/21/2009 | US7563771 Polypeptide with specific amino acid sequence enhances binding of low-density lipoprotein (LDL) or very low density lipoprotein (VLDL) to a cell, thus reducing the cholesterol and other cardiovascular disorders |
| 07/21/2009 | US7563770 Pharmacokinetics; chemical stability; gene therapy |
| 07/21/2009 | US7563769 Fibroblast growth factor (FGF); enhanced receptor subtype specificity and/or affinity; for treatment of skeletal dysplasia, osteoporosis and enhancing bone fracture healing and cartilage healing processes; mitogens |
| 07/21/2009 | US7563768 Administering hepatocyte growth factor to suppress inflammation |
| 07/21/2009 | US7563767 Functional genomics, bioinformatics |
| 07/21/2009 | US7563766 Methods and compositions for the promotion of a hair growth utilizing actin binding peptides |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | US7563764 monomeric tri-peptide units (XZX)n; X is a hydrophobic amino acid selected from Leu and Ala, with the proviso that only one Ala residue is permitted per monomeric tri-peptide unit;Z is a cationic amino acid selected from Lys, Orn, Dab; low hemolytic activity; pharmaceutical, food, agriculature, health |
| 07/21/2009 | US7563763 FSH and FSH variant formulations, products and methods |
| 07/21/2009 | US7563762 Composition and process for stabilizing of biomolecules |
| 07/21/2009 | US7563761 PNA conjugate for the treatment of diseases associated with HIV |
| 07/21/2009 | US7563760 P-selectin ligand protein |
| 07/21/2009 | US7563613 Using bioparticles partition (enzymes) to biotransform toxin or drug targets; for reducing chemical concentrations and biological effects of drugs, sarin, mustard gas, or nerve gas |
| 07/21/2009 | US7563612 Androgen-excess-mediated disease conditions; immunocontraception; polycystic ovarian syndrome, Klinefelter's Syndrome, and prostatic hyperplasia |
| 07/21/2009 | US7563599 Reshaped human antibody to human medulloblastoma cells |
| 07/21/2009 | US7563596 Isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation; binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes |
| 07/21/2009 | US7563586 Tetrodotoxin resistant membrane protein for use in pain management |
| 07/21/2009 | US7563585 Drug screening for inhibitors of the IL-4 receptor-mediated signaling cascade involved in B-cell isotype switching to, and consequent production of, IgE; allergies, eczema, asthma |
| 07/21/2009 | US7563583 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells |
| 07/21/2009 | US7563582 Identifying chemical compounds which are capable of modulating the interaction between vasodilator-stimulated phosphoprotein and zyxin |
| 07/21/2009 | US7563568 Using nucleic acid hybridization and visual analysis to identify translocations, aneuploidys, large insertions, large deletions, chromosome rearrangement/breaks along chromosome 12q15; diagnosing cancer, asthma and inflammatory disorders |
| 07/21/2009 | US7563459 Administering a glycoconjugated asialoorosomucoid and the stem cell to the mammal for drug delivering to a target tissue; regenerating heart tissue; tissue-targeted therapy, gene therapy |
| 07/21/2009 | US7563458 Nutritional compositions for nutritional management of patients with liver disease |
| 07/21/2009 | US7563455 matrix formed of lyophilized collagen and particulate biocompatible mineral embedded within, and a bone morphogenic protein to stimulate both osteoblasts and osteoclasts; for use in bone repair, bone disorders; induce bone growth |
| 07/21/2009 | US7563450 UL16 binding protein 4 |
| 07/21/2009 | US7563446 Administering a phosphatidylserine/polypeptide conjugate with polypeptide being bovine serum albumin, keyhole limpet hemocyanin, bovine gamma-globulin, diphtheria toxin, or beta 2-glycoprotein |
| 07/21/2009 | US7563445 Tumor antigens/vaccines such as cytotoxic T-lymphocytes (CTL) |
| 07/21/2009 | US7563440 vaccination against malaria comprising epitopes contained within merozoite surface proteins (MSP) or polypeptides, and carriers such as alums and/or freund's adjuvants; inoculation; immunology |
| 07/21/2009 | US7563438 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 07/21/2009 | US7563278 Drug-eluting intravascular prostheses and methods of use |
| 07/21/2009 | CA2474698C Polymer-based compositions for sustained release |
| 07/21/2009 | CA2409845C Active substance combination containing a compound with an opioid effect and at least one further compound of formula i |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/21/2009 | CA2328528C Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 07/21/2009 | CA2261690C Antiprotozoal composition |
| 07/16/2009 | WO2009089535A2 Polypeptide vaccine and vaccination strategy against mycobacterium |
| 07/16/2009 | WO2009089502A1 Inhibitors of iap |
| 07/16/2009 | WO2009089461A1 Plexind1 agonists and their use |
| 07/16/2009 | WO2009089450A1 Synthesis of macrocyclic cancer chemotherapy agents and methods of use |
| 07/16/2009 | WO2009089396A2 Glycoconjugation of polypeptides using oligosaccharyltransferases |
| 07/16/2009 | WO2009089368A1 Wound healing peptides and methods of use thereof |
| 07/16/2009 | WO2009089362A1 Methods of treatment using agents for regulating fas receptor function in skin and hair related pathologies |
| 07/16/2009 | WO2009089181A1 Insulin formulations for insulin release as a function of tissue glucose levels |
| 07/16/2009 | WO2009089121A2 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 07/16/2009 | WO2009089062A2 Cadherin-11 ec1 domain antagonists for treating inflammatory joint disorders |
| 07/16/2009 | WO2009089036A2 Therapeutic compositions for treatment of ocular inflammatory disorders |
| 07/16/2009 | WO2009088992A2 Ribonuclease and thiazolidinedione compounds and their use in methods to treat cancer |
| 07/16/2009 | WO2009088975A2 Methods and compositions for non-covalently enhanced receptor binding |
| 07/16/2009 | WO2009088949A1 Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them |
| 07/16/2009 | WO2009088931A1 Method of selecting soybeans with enhanced bioactivity and compositions for reducing cancer cell viability |
| 07/16/2009 | WO2009088753A1 Isomerases, nucleic acids encoding them and methods for making and using them |
| 07/16/2009 | WO2009088572A2 Method of treating erythropoietin hyporesponsive anemias |
| 07/16/2009 | WO2009088570A1 Stable aqueous cyclosporin compositions |
| 07/16/2009 | WO2009088314A1 Method for producing a biologically active complex exhibiting neuroregenerative and neuroprotective activity |
| 07/16/2009 | WO2009088264A2 A composition containing arazyme for the prevention and treatment of arthritis |
| 07/16/2009 | WO2009087634A2 Methods and compositions for oral administration of insulin |
| 07/16/2009 | WO2009087633A2 Methods and compositions for oral administration of protein and peptide therapeutic agents |
| 07/16/2009 | WO2009087622A2 Sldlr in viral hepatitis |
| 07/16/2009 | WO2009087560A1 Clottable concentrate of platelet growth factors and preparation method thereof |
| 07/16/2009 | WO2009087485A2 Topical compositions for delivery of proteins and peptides |
| 07/16/2009 | WO2009087424A2 Proteinaceous compounds |
| 07/16/2009 | WO2009087263A1 Composition for improving liver metabolism and diagnostic method |
| 07/16/2009 | WO2009087117A1 Use of peptides for promoting wound healing |
| 07/16/2009 | WO2009086934A1 Composition for treating scalp and skin |
| 07/16/2009 | WO2009086591A1 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 07/16/2009 | WO2009086572A1 Treatment of fibroses and liver disorders |
| 07/16/2009 | WO2009070210A3 Sustained release of apo a-i mimetic peptides and methods for delivery in situ |
| 07/16/2009 | WO2009070209A3 Sustained release of apo a-i mimetic peptides and methods of producing them |
| 07/16/2009 | WO2009068708A3 Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof |
| 07/16/2009 | WO2009067791A4 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent |
| 07/16/2009 | WO2009053064A8 Sdf-1-based glycosaminoglycan antagonists and methods of using same |